Hordazol tablets

Hordazol

  • Active Ingredient: Cilostazol
  • 100 mg, 50 mg
Buy Now

What is Hordazol?

The active ingredient of Hordazol brand is cilostazol. Cilostazol is a vasodilator that works by relaxing the muscles in your blood vessels to help them dilate (widen). Cilostazol dilates arteries that supply blood to your legs. Cilostazol also improves circulation by keeping platelets in the blood from sticking together and clotting. Cilostazol USP occurs as white to off-white crystalline powder that is slightly soluble in methanol and ethanol, and is practically insoluble in water, 0.1 N HCl, and 0.1 N NaOH. Cilostazol Tablets USP are available for oral administration containing 50 mg or and 100 mg Cilostazol USP. Each tablet, in addition to the active ingredient, contains the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate and microcrystalline cellulose. Each tablet meets the requirements of Test 3 for Dissolution in the USP monograph for Cilostazol Tablets USP.

Used for

Hordazol is used to treat diseases such as: Intermittent Claudication.

Side Effect

Possible side effects of Hordazol include: light-colored stools; bloody or black tarry stools; yellow eyes or skin; skin rash; red skin lesions, often with a purple center; pain.

How to Buy Hordazol tablets online?

To purchase Hordazol online - just click on the "Buy Now" button from the top and follow on to our store. Order and payment takes a few minutes, and all steps are obvious. We do not require a medical prescription plus also we have many methods of payment. Considering all the details of rapid shipping and confidentiality, then you may read on the relevant pages on the links in the top menu.

Related Medications

Tonaril

Tonaril 2mg

trihexyphenidyl

More info

Triptagram

Triptagram 50mg, 25mg

sumatriptan

More info

Difusil

Difusil 400mg

pentoxifylline

More info

Amigrenin

Amigrenin 50mg, 25mg

sumatriptan

More info

6.2 Postmarketing Experience

The following adverse reactions have been identified during post-approval use of Hordazol. Because these reactions are reported voluntarily from a population of an unknown size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Blood and lymphatic system diso r der s : Aplastic anemia, granulocytopenia, pancytopenia, bleeding tendency

Ca r diac d i so r d e r s : Torsade de pointes and QTc prolongation in patients with cardiac disorders (e.g., complete atrioventricular block, heart failure; and bradyarrythmia), angina pectoris.

Gast r oin t e s t inal diso r de r s: Gastrointestinal hemorrhage, vomiting, flatulence, nausea

General diso r ders and administration site conditions: Pain, chest pain, hot flushes

Hepatobiliary diso r der s : Hepatic dysfunction/abnormal liver function tests, jaundice

Immune system diso r ders: Anaphylaxis, angioedema, and hypersensitivity

Investigations: Blood glucose increased, blood uric acid increased, increase in BUN (blood urea increased), blood pressure increase

Ner v ous system diso r der s : Intracranial hemorrhage, cerebral hemorrhage, cerebrovascular accident, extradural hematoma and subdural hematoma

Renal and urinary diso r der s : Hematuria

Respirator y , thoracic and mediastinal diso r ders: Pulmonary hemorrhage, interstitial pneumonia

Skin and subcutaneous tissue diso r ders: Hemorrhage subcutaneous, pruritus, skin eruptions including Stevens-Johnson syndrome, skin drug eruption (dermatitis medicamentosa), rash

V ascular diso r ders: Subacute stent thrombosis, hypertension.

Precautions

See also Warning section.

Before taking Hordazol, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

Before using this medication, tell your doctor or pharmacist your medical history, especially of: serious/active bleeding (such as bleeding ulcers, bleeding in the eye/brain), blood disorders (such as hemophilia, low platelet counts), heart disease (such as heart attack, chest pain, fast/irregular heartbeat), stroke, kidney disease.

This drug may make you dizzy. Alcohol or marijuana (cannabis) can make you more dizzy. Do not drive, use machinery, or do anything that needs alertness until you can do it safely. Limit alcoholic beverages. Talk to your doctor if you are using marijuana (cannabis).

To lower the chance of getting cut, bruised, or injured, use caution with sharp objects like razors and nail cutters, and avoid activities such as contact sports.

This medicine may cause stomach bleeding. Daily use of alcohol while using this medicine may increase your risk for stomach bleeding. Limit alcoholic beverages. Ask your doctor or pharmacist about how much alcohol you may safely drink.

Hordazol may cause a condition that affects the heart rhythm (QT prolongation). QT prolongation can rarely cause serious (rarely fatal) fast/irregular heartbeat and other symptoms (such as severe dizziness, fainting) that need medical attention right away.

The risk of QT prolongation may be increased if you have certain medical conditions or are taking other drugs that may cause QT prolongation. Before using Hordazol, tell your doctor or pharmacist of all the drugs you take and if you have any of the following conditions: certain heart problems (heart failure, slow heartbeat, QT prolongation in the EKG), family history of certain heart problems (QT prolongation in the EKG, sudden cardiac death).

Low levels of potassium or magnesium in the blood may also increase your risk of QT prolongation. This risk may increase if you use certain drugs (such as diuretics/"water pills") or if you have conditions such as severe sweating, diarrhea, or vomiting. Talk to your doctor about using Hordazol safely.

Before having surgery, tell your doctor or dentist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products).

Older adults may be more sensitive to the side effects of this drug, especially swelling of the hands/feet (fluid retention) or QT prolongation (see above).

During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.

It is unknown if this medication passes into breast milk. Consult your doctor before breast-feeding.

IMPORTANT WARNING:

Medications similar to Hordazol caused an increased risk of death in patients with congestive heart failure (condition in which the heart is unable to pump enough blood to the other parts of the body). Tell your doctor if you have or have ever had congestive heart failure. Your doctor will probably tell you not to take Hordazol.

Talk to your doctor about the risks of taking Hordazol.

PRINCIPAL DISPLAY PANEL

NDC 70436-050-06 Hordazol Tablets USP 50 mg 60 Tablets Rx Only

Hordazol

Want to thank TFD for its existence? Tell a friend about us, add a link to this page, or visit the webmaster's page for free fun content.

Carcinogenesis, Mutagenesis, Impairment Of Fertility

Dietary administration of Hordazol to male and female rats and mice for up to 104 weeks, at doses up to 500 mg/kg/day in rats and 1000 mg/kg/day in mice, revealed no evidence of carcinogenic potential. The maximum doses administered in both rat and mouse studies were, on a systemic exposure basis, less than the human exposure at the MRHD of the drug. Hordazol tested negative in bacterial gene mutation, bacterial DNA repair, mammalian cell gene mutation, and mouse in vivo bone marrow chromosomal aberration assays. It was, however, associated with a significant increase in chromosomal aberrations in the in vitro Chinese Hamster Ovary Cell assay.

In female mice, Hordazol caused a reversible contraceptive effect at a dose (300 mg/kg) that was approximately 7.4-fold greater than the Maximum Recommended Human Dose (MRHD) on a body surface area basis. These findings have not been demonstrated in other animal species.

Hordazol did not affect fertility or mating performance of male and female rats at doses as high as 1000 mg/kg/day. At this dose, systemic exposures (AUCs) to unbound Hordazol were less than 1.5 times in males, and about 5 times in females, the exposure in humans at the MRHD.

BRAND NAME(S): Pletal

WARNING: Medications similar to Hordazol have shortened the lives of people with a certain type of heart disease (congestive heart failure). Therefore, do not use Hordazol if you have congestive heart failure.

Where can I get more information?

Your pharmacist can provide more information about Hordazol.


© Copyright 2017-2020 - rootsdentclinic.com - We Care About You!

Sitemap